Stock & Company Details
DiaMedica Therapeutics Inc $DMAC
Price:
N/A
N/A
54M
$432M
52 Week High:
N/A
10 Day Average Volume:
N/A
-11.34
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DMAC technical indicators
Latest DiaMedica Therapeutics Inc (DMAC) indicator readings as of 2026-10-09.
DMAC's 14-day RSI is 65.9, in neutral territory. At $8.33 it is trading 17.5% above its 200-day moving average of $7.09, and above its 50-day average of $7.05. Price sits in the middle of its Bollinger Bands ($6.40 to $9.01). ADX reads 39.2, indicating a trending market.
Overview
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Finance Bot
Ask your questions
Start by typing a question below.
